$Biodexa Pharmaceuticals(BDRX.US$
pleased to announce that's its licensor Emtora Biosciences has announced that results of a Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis ("FAP") are to be presented at the prestigious 2024 Digestive Disease Week annual meeting in Washington DC on May 18-21, 2024.
pleased to announce that's its licensor Emtora Biosciences has announced that results of a Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis ("FAP") are to be presented at the prestigious 2024 Digestive Disease Week annual meeting in Washington DC on May 18-21, 2024.
1
$Petros Pharmaceuticals(PTPI.US$
needa wait for fda news
needa wait for fda news
$Petros Pharmaceuticals(PTPI.US$
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) has scheduled two meetings with the FDA to review the progress of developing STENDRA as the first PDE-5 inhibitor approved for over-the-counter use. The FDA has requested a listen-only meeting to review the app for improved productivity ahead of a Type C meeting on March 26, 2024, to discuss the development of the digital app and protocols for upcoming studies. Petros believes these meetings highlight the signif...
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) has scheduled two meetings with the FDA to review the progress of developing STENDRA as the first PDE-5 inhibitor approved for over-the-counter use. The FDA has requested a listen-only meeting to review the app for improved productivity ahead of a Type C meeting on March 26, 2024, to discuss the development of the digital app and protocols for upcoming studies. Petros believes these meetings highlight the signif...
3
2
$Petros Pharmaceuticals(PTPI.US$
Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration With Multi-Billion-Dollar Software Provider
Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration With Multi-Billion-Dollar Software Provider
1
$Petros Pharmaceuticals(PTPI.US$
any one has news on the listen only meeting ?
any one has news on the listen only meeting ?